| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699930 | Clinical Oncology | 2006 | 4 Pages |
Abstract
Symptomatic brain metastases occurred less frequently than would be expected, with most patients developing widespread metastatic disease. Low-dose PCI may benefit these groups, and the results of an ongoing EORTC randomised-controlled trial in extensive disease should provide more information.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.M. Henry, M.P. Snee,